...
accd-img

Accolade Inc, Common Stock

ACCD

NSQ

$7.33

+$0

(0%)

1D
Industry: Health Care Technology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$574.36M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
113.64K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
768.63K
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.15
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.33 L
$15.36 H
$7.33

About Accolade Inc, Common Stock

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington. more

Industry: Health Care TechnologySector: Health Care

Returns

Time FrameACCDSectorS&P500
1-Week Return0.55%1.91%1.64%
1-Month Return-12.74%5.3%5.01%
3-Month Return-40.7%0.64%6.21%
6-Month Return-3.68%14.55%18.33%
1-Year Return-30.32%13.43%30.88%
3-Year Return-82.6%24.18%33.21%
5-Year Return-75.32%79.61%99.77%

Financials

Feb '20Feb '21Feb '22Feb '23Feb '245YR TREND
Total Revenue132.51M170.36M310.02M363.14M414.29M[{"date":"2020-02-29","value":31.98,"profit":true},{"date":"2021-02-28","value":41.12,"profit":true},{"date":"2022-02-28","value":74.83,"profit":true},{"date":"2023-02-28","value":87.65,"profit":true},{"date":"2024-02-29","value":100,"profit":true}]
Cost of Revenue73.69M93.67M169.02M198.91M270.66M[{"date":"2020-02-29","value":27.22,"profit":true},{"date":"2021-02-28","value":34.61,"profit":true},{"date":"2022-02-28","value":62.45,"profit":true},{"date":"2023-02-28","value":73.49,"profit":true},{"date":"2024-02-29","value":100,"profit":true}]
Gross Profit58.82M76.69M141.00M164.24M143.63M[{"date":"2020-02-29","value":35.82,"profit":true},{"date":"2021-02-28","value":46.69,"profit":true},{"date":"2022-02-28","value":85.85,"profit":true},{"date":"2023-02-28","value":100,"profit":true},{"date":"2024-02-29","value":87.45,"profit":true}]
Gross Margin44.39%45.01%45.48%45.23%34.67%[{"date":"2020-02-29","value":97.6,"profit":true},{"date":"2021-02-28","value":98.97,"profit":true},{"date":"2022-02-28","value":100,"profit":true},{"date":"2023-02-28","value":99.44,"profit":true},{"date":"2024-02-29","value":76.23,"profit":true}]
Operating Expenses107.03M123.46M312.14M328.05M257.22M[{"date":"2020-02-29","value":32.63,"profit":true},{"date":"2021-02-28","value":37.64,"profit":true},{"date":"2022-02-28","value":95.15,"profit":true},{"date":"2023-02-28","value":100,"profit":true},{"date":"2024-02-29","value":78.41,"profit":true}]
Operating Income(48.20M)(46.78M)(171.14M)135.90M(113.59M)[{"date":"2020-02-29","value":-35.47,"profit":false},{"date":"2021-02-28","value":-34.42,"profit":false},{"date":"2022-02-28","value":-125.94,"profit":false},{"date":"2023-02-28","value":100,"profit":true},{"date":"2024-02-29","value":-83.59,"profit":false}]
Total Non-Operating Income/Expense(5.96M)(7.59M)39.47M(598.91M)20.97M[{"date":"2020-02-29","value":-15.09,"profit":false},{"date":"2021-02-28","value":-19.24,"profit":false},{"date":"2022-02-28","value":100,"profit":true},{"date":"2023-02-28","value":-1517.28,"profit":false},{"date":"2024-02-29","value":53.13,"profit":true}]
Pre-Tax Income(51.24M)(50.65M)(128.76M)(463.27M)(98.57M)[{"date":"2020-02-29","value":-5123600000,"profit":false},{"date":"2021-02-28","value":-5064800000,"profit":false},{"date":"2022-02-28","value":-12876300000,"profit":false},{"date":"2023-02-28","value":-46327400000,"profit":false},{"date":"2024-02-29","value":-9857000000,"profit":false}]
Income Taxes129.00K4.00K(5.64M)(3.62M)1.24M[{"date":"2020-02-29","value":10.45,"profit":true},{"date":"2021-02-28","value":0.32,"profit":true},{"date":"2022-02-28","value":-456.6,"profit":false},{"date":"2023-02-28","value":-293.44,"profit":false},{"date":"2024-02-29","value":100,"profit":true}]
Income After Taxes(51.37M)(50.65M)(123.12M)(459.65M)(99.81M)[{"date":"2020-02-29","value":-5136500000,"profit":false},{"date":"2021-02-28","value":-5065200000,"profit":false},{"date":"2022-02-28","value":-12312400000,"profit":false},{"date":"2023-02-28","value":-45965000000,"profit":false},{"date":"2024-02-29","value":-9980500000,"profit":false}]
Income From Continuous Operations(51.37M)(50.65M)(123.12M)(459.65M)(99.81M)[{"date":"2020-02-29","value":-5136500000,"profit":false},{"date":"2021-02-28","value":-5065200000,"profit":false},{"date":"2022-02-28","value":-12312400000,"profit":false},{"date":"2023-02-28","value":-45965000000,"profit":false},{"date":"2024-02-29","value":-9980500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-02-29","value":"-","profit":true},{"date":"2021-02-28","value":"-","profit":true},{"date":"2022-02-28","value":"-","profit":true},{"date":"2023-02-28","value":"-","profit":true},{"date":"2024-02-29","value":"-","profit":true}]
Net Income(51.37M)(50.65M)(123.12M)(459.65M)(99.81M)[{"date":"2020-02-29","value":-5136500000,"profit":false},{"date":"2021-02-28","value":-5065200000,"profit":false},{"date":"2022-02-28","value":-12312400000,"profit":false},{"date":"2023-02-28","value":-45965000000,"profit":false},{"date":"2024-02-29","value":-9980500000,"profit":false}]
EPS (Diluted)(0.88)(2.87)(1.83)(2.26)(1.33)[{"date":"2020-02-29","value":-88,"profit":false},{"date":"2021-02-28","value":-287,"profit":false},{"date":"2022-02-28","value":-183,"profit":false},{"date":"2023-02-28","value":-226,"profit":false},{"date":"2024-02-29","value":-133,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ACCD
Cash Ratio 2.20
Current Ratio 2.60
Quick Ratio 2.60

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ACCD
ROA (LTM) -8.40%
ROE (LTM) -21.71%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ACCD
Debt Ratio Lower is generally better. Negative is bad. 0.43
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.57
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 1.77

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ACCD
Trailing PE NM
Forward PE NM
P/S (TTM) 1.64
P/B 1.47
Price/FCF 149
EV/R 1.67
EV/Ebitda NM
PEG NM

News

AusVintage turmoil may strengthen Accolade’s hand: Allan Gray

The boss of Allan Gray, with a 17pc stake in Australian Vintage, is concerned larger player Accolade Wines may seize on management upheaval to drive a harder bargain.

6 May, 2024 a 6:15 am The Australian Financial Review

McGuigan owner Australian Vintage dumps CEO over ‘conduct’ issues

The ousted CEO of Australian Vintage, Craig Garvin, is ‘considering legal options’, while the chairman says his exit won’t have an impact on merger talks with Accolade.

5 May, 2024 a 3:37 am The Australian Financial Review

Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration

Accolade, Inc. (ACCD) has disclosed a new risk, in the Regulation category. Accolade, Inc. faces significant business risk as it integrates AI into…

27 Apr, 2024 a 6:01 am TipRanks

ACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024

Accolade (NASDAQ: ACCD ) just reported results for the fourth quarter of 2024. Accolade reported earnings per share of -10 cents. This was below the analyst estimate for EPS of -7 cents. The company reported revenue of $124.83 million. This was 0.74% better than the analyst estimate for revenue of $123.91 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.

26 Apr, 2024 a 12:55 am InvestorPlace

Marc Andreessen, Galaxy Digital, Accolade, back new $75 million crypto fund: Report

The fund was announced during an uptick of institutional interest in crypto investments. Prominent venture capitalists Marc Andreessen, Galaxy Digital, and Accolade Partners are among the top contributors to crypto venture capital (VC) firm 1kxs latest fund. 1kx raised $75 million, with Chris Dixon, a partner at Andreessen Horowitz, as one of the limited partners, Lasse Clausen, the founding partner of 1kx, told Bloomberg on March 28. Private equity firm Accolade is the anchor investor in the new fund, according to Clausen. Read more

28 Mar, 2024 a 12:23 pm Coin Telegraph

Backdoor listing for Accolade on the table in AusVintage deal

The largest shareholder in Australian Vintage, which owns the McGuigan and Tempus Two wine brands, says a Chemist Warehouse-style listing of Accolade makes sense.

24 Mar, 2024 a 6:00 pm The Australian Financial Review

FAQs

What is Accolade Inc share price today?

Accolade Inc (ACCD) share price today is $7.33

Can Indians buy Accolade Inc shares?

Yes, Indians can buy shares of Accolade Inc (ACCD) on Vested. To buy Accolade Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ACCD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Accolade Inc be purchased?

Yes, you can purchase fractional shares of Accolade Inc (ACCD) via the Vested app. You can start investing in Accolade Inc (ACCD) with a minimum investment of $1.

How to invest in Accolade Inc shares from India?

You can invest in shares of Accolade Inc (ACCD) via Vested in three simple steps:

  • Click on Sign Up or Invest in ACCD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Accolade Inc shares
What is Accolade Inc 52-week high and low stock price?

The 52-week high price of Accolade Inc (ACCD) is $15.36. The 52-week low price of Accolade Inc (ACCD) is $6.33.

What is Accolade Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Accolade Inc (ACCD) is NM

What is Accolade Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Accolade Inc (ACCD) is 1.47

What is Accolade Inc dividend yield?

The dividend yield of Accolade Inc (ACCD) is 0.00%

What is the Market Cap of Accolade Inc?

The market capitalization of Accolade Inc (ACCD) is $574.36M

What is Accolade Inc’s stock symbol?

The stock symbol (or ticker) of Accolade Inc is ACCD

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top